Zdrowie i gospodarka · 19/12/2025
FDA Clears EFFEXOR XR for Continued Sale
The FDA has determined that the 100mg EFFEXOR XR extended-release capsule was not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications for the product.